(Q36565624)

English

CF102 for the treatment of hepatocellular carcinoma: a phase I/II, open-label, dose-escalation study

scientific article published on 8 January 2013

Statements

CF102 for the treatment of hepatocellular carcinoma: a phase I/II, open-label, dose-escalation study (English)
Salomon M Stemmer
Ofer Benjaminov
Michael H Silverman
Sara Bar-Yehuda
Motti Farbstein
William D Kerns

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit